b.brandt

TL2 · Bursa

Contributes reviews on supplier material. Based in Bursa.

Joined 2 February 2025 · last posted 2d

85Posts here

1Topics

0Solutions

1.1kLikes received

811Likes given

21Badges

167Days visited

2.7kPosts read

Recent activity

Full stream

How shortages have affected compounding permissions Replied, post #72 · Access › Shortages · 26 Jul 2026 · 9 likes On shortages I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how threads get…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #49 · Clinical › Prescriber conversations · 25 Jul 2026 · 13 likes A pharmacist can answer a great many of the questions people save for a prescriber, faster and often better, particularly about interactions and formulations. It is the…
Documenting a supplier's response to a discrepancy Replied, post #34 · Sourcing › Vendor reports · 9 Jul 2026 · 7 likes Do not adjust a reported figure. Post what the laboratory said and put your interpretation in a separate sentence. That much is documented. The rest is how I have…
Request: a per-category review queue Replied, post #75 · Meta › Feature requests · 2 Jul 2026 · 1 like Use case: explain why you think the feature would help. "I would use this to..." makes the request concrete. I would hold that lightly until someone with a larger…
Retatrutide mass and identity: what a report should show Replied, post #8 · Compounds › Retatrutide · 2 Jul 2026 · 1 like Why this subcategory is more cautious than elsewhere: retatrutide is investigational, phase 3 is ongoing, and the heart-rate signal in phase 2 is not negligible.…
How shortages have affected compounding permissions Replied, post #9 · Access › Shortages · 1 Jul 2026 · 6 likes I have been on both sides of the shortages argument in this category within eighteen months, which should tell you how strong the evidence for either side is.
Why fasting instructions for oral semaglutide are not optional advice Replied, post #48 · Compounds › Oral incretins · 18 Jun 2026 · 28 likes Post #47 answers the question as asked. The question underneath it is different. Research-use-only oral material is not a licensed tablet and there is no reason to…
Bioimpedance and hydration: why the number moves Replied, post #62 · Outcomes › Body composition · 18 Jun 2026 · 18 likes The arithmetic in post #60 is right; the assumption feeding it is the part to check. Neither method is capable of detecting the month-to-month changes that people…
Revisiting: Taste changes and food aversion, reported and discussed Replied, post #4 · Practice › Side effects · 10 Jun 2026 · 0 likes The opening post is the version of this I will quote in future. One addition. I disagree with the framing of Taste changes and food aversion above, and I think it is a…
Official shortage notices and what they authorise Replied, post #96 · Access › Shortages · 9 Jun 2026 · 3 likes Narrowing post #93, because the general version has more than one answer. Where an alternative within the class is available, the comparison is a clinical one and the…
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #5 · Access › International · 8 Jun 2026 · 0 likes Everything in the opening post holds. The case it does not cover is the one I have. Travel with medication: carrying a compound across borders is complicated by legal…
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #92 · Sourcing › Red flags · 6 Jun 2026 · 1 like Coming back to post #88, because the follow-up matters more than the original answer. Where somebody posts a concern, ask what would resolve it before arguing about it.…